CDK4/6 inhibitors in hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: Are we at the finish line?

Clinton Yam, Mien Chie Hung, Gabriel N. Hortobagyi

Research output: Contribution to journalEditorialpeer-review

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)34193-34195
Number of pages3
JournalOncotarget
Volume9
Issue number76
DOIs
StatePublished - Sep 1 2018

Keywords

  • CDK4/6 inhibitors
  • Hormone receptor-positive
  • Metastatic breast cancer

ASJC Scopus subject areas

  • Oncology

Cite this